Gene Review:
Apoc3 - apolipoprotein C-III
Mus musculus
Synonyms:
Apo-CIII, ApoC-III, Apolipoprotein C-III, Apolipoprotein C3, apo-CIII, ...
- Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. Maeda, N., Li, H., Lee, D., Oliver, P., Quarfordt, S.H., Osada, J. J. Biol. Chem. (1994)
- Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. Schissel, S.L., Jiang, X., Tweedie-Hardman, J., Jeong, T., Camejo, E.H., Najib, J., Rapp, J.H., Williams, K.J., Tabas, I. J. Biol. Chem. (1998)
- Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice. Jeong, S., Kim, M., Han, M., Lee, H., Ahn, J., Kim, M., Song, Y.H., Shin, C., Nam, K.H., Kim, T.W., Oh, G.T., Yoon, M. Metab. Clin. Exp. (2004)
- Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. Li, W.W., Dammerman, M.M., Smith, J.D., Metzger, S., Breslow, J.L., Leff, T. J. Clin. Invest. (1995)
- Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Claudel, T., Inoue, Y., Barbier, O., Duran-Sandoval, D., Kosykh, V., Fruchart, J., Fruchart, J.C., Gonzalez, F.J., Staels, B. Gastroenterology (2003)
- Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes. Juntti-Berggren, L., Refai, E., Appelskog, I., Andersson, M., Imreh, G., Dekki, N., Uhles, S., Yu, L., Griffiths, W.J., Zaitsev, S., Leibiger, I., Yang, S.N., Olivecrona, G., Jörnvall, H., Berggren, P.O. Proc. Natl. Acad. Sci. U.S.A. (2004)
- The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV gene. Le Beyec, J., Chauffeton, V., Kan, H.Y., Janvier, P.L., Cywiner-Golenzer, C., Chatelet, F.P., Kalopissis, A.D., Zannis, V., Chambaz, J., Pinçon-Raymond, M., Cardot, P. J. Biol. Chem. (1999)
- Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice. Takahashi, T., Hirano, T., Okada, K., Adachi, M. Metab. Clin. Exp. (2003)
- Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: genomic, mRNA, and protein sequences with comparisons to other species. Januzzi, J.L., Azrolan, N., O'Connell, A., Aalto-Setälä, K., Breslow, J.L. Genomics (1992)
- Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. Jong, M.C., Rensen, P.C., Dahlmans, V.E., van der Boom, H., van Berkel, T.J., Havekes, L.M. J. Lipid Res. (2001)
- Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Kawakami, A., Aikawa, M., Libby, P., Alcaide, P., Luscinskas, F.W., Sacks, F.M. Circulation (2006)
- ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression. Gerritsen, G., Rensen, P.C., Kypreos, K.E., Zannis, V.I., Havekes, L.M., Willems van Dijk, K. J. Lipid Res. (2005)
- Apolipoprotein C-III can specifically bind to hepatic plasma membranes. Fang, D.Z., Liu, B.W. Mol. Cell. Biochem. (2000)
- Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice. Yoon, M., Jeong, S., Lee, H., Han, M., Kang, J.H., Kim, E.Y., Kim, M., Oh, G.T. Biochem. Biophys. Res. Commun. (2003)
- Association between the SstI polymorphism of the apolipoprotein C-III gene, glucose intolerance and cardiovascular risk in renal transplant recipients. Rodrigo, E., González-Lamuño, D., Ruiz, J.C., Fresnedo, G.F., Isla, D., Cotorruelo, J.G., Zubimendi, J.A., de Francisco, A.L., Garcia-Fuentes, M., Arias, M. Transplant. Proc. (2002)
- Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter. Palmer, C.N., Hsu, M.H., Muerhoff, A.S., Griffin, K.J., Johnson, E.F. J. Biol. Chem. (1994)